CEN Biotech Inc (CENBF)
0.0002
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
CEN Biotech Cash from Financing (Quarterly): 0.00 for March 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.0543M |
| September 30, 2022 | -0.0098M |
| June 30, 2022 | 0.4763M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.11M |
| September 30, 2021 | 0.0044M |
| June 30, 2021 | 0.2964M |
| March 31, 2021 | 0.11M |
| December 31, 2020 | -0.03M |
| September 30, 2020 | 0.249M |
| June 30, 2020 | 0.072M |
| March 31, 2020 | 0.178M |
| December 31, 2019 | 0.3564M |
| September 30, 2019 | 0.1565M |
| June 30, 2019 | 0.40M |
| March 31, 2019 | 0.147M |
| Date | Value |
|---|---|
| December 31, 2018 | 0.1672M |
| September 30, 2018 | 0.5177M |
| June 30, 2018 | 0.192M |
| March 31, 2018 | 0.8708M |
| December 31, 2017 | 0.9002M |
| September 30, 2017 | 0.61M |
| June 30, 2017 | 0.1335M |
| March 31, 2017 | 1.066M |
| December 31, 2016 | 0.4957M |
| September 30, 2016 | 0.0808M |
| June 30, 2016 | 0.5323M |
| March 31, 2016 | 0.0875M |
| December 31, 2015 | -0.143M |
| September 30, 2015 | 0.1342M |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.2789M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.03M
Minimum
Dec 2020
0.4763M
Maximum
Jun 2022
0.1515M
Average
0.11M
Median
Mar 2021
Cash from Financing (Quarterly) Benchmarks
| Halo Collective Inc | -0.4607M |
| Neovasc Inc (DELISTED) | -0.0725M |
| InMed Pharmaceuticals Inc | 0.00 |
| Venus Concept Inc | 1.271M |
| Lucy Scientific Discovery Inc | 0.757M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 0.1023M |
| Cash from Investing (Quarterly) | -0.0496M |
| Free Cash Flow | -0.2248M |
| Free Cash Flow Per Share (Quarterly) | 0.0008 |
| Free Cash Flow to Equity (Quarterly) | 0.0833M |
| Free Cash Flow to Firm (Quarterly) | 0.0902M |